# A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

> **NCT00096655** · PHASE3 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 364 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00096655
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096655, "A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00096655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*